Hypoglycemic Efficacy of Rh-aFGF Variants in Treatment of Diabetes in ZDF Rats

Acidic fibroblast growth factor (aFGF) is a promising regulator of glucose with no adverse effects of hypoglycemia. Previous researches revealed that aFGF mediated adipose tissue remodeling and insulin sensitivity. These findings supported rh-aFGF(135) would be used as a new candidate for the treatm...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Li, Zhou, Qingde, Chen, Min, Yang, Xuanxin, Lu, Chao, Sun, Wenzhe, Hui, Qi, Wang, Xiaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930327/
https://www.ncbi.nlm.nih.gov/pubmed/33681196
http://dx.doi.org/10.3389/fcell.2021.609383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930327/
https://www.ncbi.nlm.nih.gov/pubmed/33681196
http://dx.doi.org/10.3389/fcell.2021.609383

Ejemplares similares